4DMT

4DMT is a biotechnology company that researches, develops and commercializes gene therapeutics for the treatment of cancer.

Business Model:

Revenue: $2M

Employees: 51-200

Detailed 4DMT Information

Geographic Data

4DMT headquarters map

Address: 5858 Horton Street

City: Emeryville

State: CA

Zip: 94608

Country: US

Financial Info

Stage:

series c

Raised Last:

$75M

Raised Total:

$175M

Metrics

3,368,762Website Global Rank

4,383Website Monthly Traffic

Twitter Followers

Description

4DMT is a biotechnology company that researches, develops and commercializes gene therapeutics for the treatment of cancer.

Contact Phone:
+15105052680

Contact Email:

4DMT went public on 12/10/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
12/10/2020

IPO Valuation:
$580M

Ticker Symbol:
FDMT

IPO Price:
$23/share

Amount Raised:
$193M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2016 Series A -
9/2017 Venture Round 1 $3M Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
8/2015 Venture Round $7M
12/2020 IPO $193.2M
8/2018 Series B $90M Viking Global Investors
ArrowMark Partners
Janus Henderson Investors
The Biotechnology Value Fund
Mirae Asset Financial Group
Pappas Capital
Chiesi Ventures
Perceptive Advisors
Ridgeback Capital Investments
Biotechnology Value Fund
CureDuchenne Ventures
6/2020 Series C $0 Amzak Health Investors
ArrowMark Partners
Berkeley Catalyst Fund (BCF)
BVF Partners
Casdin Capital
Chiesi Ventures
Cystic Fibrosis Foundation
Longevity Vision Fund
MiraeAsset Financial Group
Octagon Capital Partners
Pappas Capital
Perceptive Advisors
Pfizer Venture Investments
QUAD Investment Management
Ridgeback Capital
Viking Global Investors
Amzak Health Investors
ArrowMark Partners
Berkeley Catalyst Fund (BCF)
BVF Partners
Casdin Capital
Chiesi Ventures
Cystic Fibrosis Foundation
Longevity Vision Fund
MiraeAsset Financial Group
Octagon Capital Partners
Pappas Capital
Perceptive Advisors
Pfizer Venture Investments
QUAD Investment Management
Ridgeback Capital
Viking Global Investors
9/2018 Series B $0 Pfizer Venture Investments
Viking Global Investors
Chiesi Ventures
Ridgeback Capital
Perceptive Advisors
Pappas Capital
Mirae Asset
Janus Henderson Investors
CureDuchenne Ventures
Biotechnology Value Fund
Pfizer Venture Investments
Viking Global Investors
Chiesi Ventures
Ridgeback Capital
Perceptive Advisors
Pappas Capital
Mirae Asset
Janus Henderson Investors
CureDuchenne Ventures
Biotechnology Value Fund
6/2020 Series C 16 $75M Viking Global Investors
Amzak Health
Casdin Capital
Cystic Fibrosis Foundation
Longevity Vision Fund
MiraeAsset Financial Group
Octagon Investments
QUAD Investment Management
Arrowmark Partners
Berkeley Catalyst Fund
BVF Partners L.P.
Pappas Capital
Chiesi Ventures
Perceptive Advisors
Ridgeback Capital Investments
Amzak Health Investors
ArrowMark Partners
Berkeley Catalyst Fund (BCF)
BVF Partners
Casdin Capital
Chiesi Ventures
Cystic Fibrosis Foundation
Longevity Vision Fund
MiraeAsset Financial Group
Octagon Capital Partners
Pappas Capital
Perceptive Advisors
Pfizer Venture Investments
QUAD Investment Management
Ridgeback Capital
Viking Global Investors
1/2016 Series A - Pfizer Inc.
Pfizer Inc.
9/2018 Series B 12 $90M Pfizer Venture Investments
Viking Global Investors
Pfizer Venture Investments
Viking Global Investors
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research